vs
MARAVAI LIFESCIENCES HOLDINGS, INC.（MRVI）与READING INTERNATIONAL INC（RDI）财务数据对比。点击上方公司名可切换其他公司
READING INTERNATIONAL INC的季度营收约是MARAVAI LIFESCIENCES HOLDINGS, INC.的1.0倍（$50.3M vs $49.9M），READING INTERNATIONAL INC净利率更高（-5.1% vs -71.6%，领先66.5%），MARAVAI LIFESCIENCES HOLDINGS, INC.同比增速更快（-11.8% vs -14.2%），READING INTERNATIONAL INC自由现金流更多（$4.1M vs $-24.9M），过去两年READING INTERNATIONAL INC的营收复合增速更高（5.6% vs -11.9%）
Maravai生命科学控股是一家全球化生命科学企业，专注于开发供应关键试剂、诊断产品及技术解决方案，服务于生物制药研发、药物开发、临床诊断及细胞和基因疗法制造领域，客户覆盖全球相关科研、医疗和企业机构。
雷丁公司是总部位于美国费城的铁路企业，1924年起在宾夕法尼亚州东部及周边各州提供客运与货运运输服务，直至1976年被联合铁路公司收购。
MRVI vs RDI — 直观对比
营收规模更大
RDI
是对方的1.0倍
$49.9M
营收增速更快
MRVI
高出2.3%
-14.2%
净利率更高
RDI
高出66.5%
-71.6%
自由现金流更多
RDI
多$29.0M
$-24.9M
两年增速更快
RDI
近两年复合增速
-11.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $49.9M | $50.3M |
| 净利润 | $-35.7M | $-2.6M |
| 毛利率 | 25.8% | — |
| 营业利润率 | -117.9% | -1.9% |
| 净利率 | -71.6% | -5.1% |
| 营收同比 | -11.8% | -14.2% |
| 净利润同比 | -37.7% | -14.5% |
| 每股收益（稀释后） | $-0.24 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MRVIRDI
| Q4 25 | $49.9M | $50.3M | ||
| Q3 25 | $41.6M | $52.2M | ||
| Q2 25 | $47.4M | $60.4M | ||
| Q1 25 | $46.9M | $40.2M | ||
| Q4 24 | $56.6M | $58.6M | ||
| Q3 24 | $69.0M | $60.1M | ||
| Q2 24 | $69.4M | $46.8M | ||
| Q1 24 | $64.2M | $45.1M |
净利润MRVIRDI
| Q4 25 | $-35.7M | $-2.6M | ||
| Q3 25 | $-25.6M | $-4.2M | ||
| Q2 25 | $-39.6M | $-2.7M | ||
| Q1 25 | $-29.9M | $-4.8M | ||
| Q4 24 | $-25.9M | $-2.2M | ||
| Q3 24 | $-97.1M | $-7.0M | ||
| Q2 24 | $-9.8M | $-12.8M | ||
| Q1 24 | $-12.1M | $-13.2M |
毛利率MRVIRDI
| Q4 25 | 25.8% | — | ||
| Q3 25 | 13.6% | — | ||
| Q2 25 | 16.4% | — | ||
| Q1 25 | 16.5% | — | ||
| Q4 24 | 34.3% | — | ||
| Q3 24 | 46.7% | — | ||
| Q2 24 | 44.4% | — | ||
| Q1 24 | 40.3% | — |
营业利润率MRVIRDI
| Q4 25 | -117.9% | -1.9% | ||
| Q3 25 | -98.6% | -0.6% | ||
| Q2 25 | -139.8% | 4.8% | ||
| Q1 25 | -104.9% | -17.2% | ||
| Q4 24 | -66.7% | 2.6% | ||
| Q3 24 | -239.9% | -0.6% | ||
| Q2 24 | -19.4% | -16.4% | ||
| Q1 24 | -29.4% | -16.7% |
净利率MRVIRDI
| Q4 25 | -71.6% | -5.1% | ||
| Q3 25 | -61.4% | -8.0% | ||
| Q2 25 | -83.5% | -4.4% | ||
| Q1 25 | -63.9% | -11.8% | ||
| Q4 24 | -45.8% | -3.8% | ||
| Q3 24 | -140.6% | -11.7% | ||
| Q2 24 | -14.1% | -27.4% | ||
| Q1 24 | -18.8% | -29.4% |
每股收益（稀释后）MRVIRDI
| Q4 25 | $-0.24 | $-0.11 | ||
| Q3 25 | $-0.18 | $-0.18 | ||
| Q2 25 | $-0.27 | $-0.12 | ||
| Q1 25 | $-0.21 | $-0.21 | ||
| Q4 24 | $-0.21 | $-0.11 | ||
| Q3 24 | $-0.68 | $-0.31 | ||
| Q2 24 | $-0.07 | $-0.57 | ||
| Q1 24 | $-0.09 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $216.9M | $10.5M |
| 总债务越低越好 | $291.8M | $185.1M |
| 股东权益账面价值 | $212.4M | $-18.2M |
| 总资产 | $770.6M | $434.9M |
| 负债/权益比越低杠杆越低 | 1.37× | — |
8季度趋势，按日历期对齐
现金及短期投资MRVIRDI
| Q4 25 | $216.9M | $10.5M | ||
| Q3 25 | $243.6M | $8.1M | ||
| Q2 25 | $269.9M | $9.1M | ||
| Q1 25 | $285.1M | $5.9M | ||
| Q4 24 | $322.4M | $12.4M | ||
| Q3 24 | $578.2M | $10.1M | ||
| Q2 24 | $573.2M | $9.3M | ||
| Q1 24 | $561.7M | $7.5M |
总债务MRVIRDI
| Q4 25 | $291.8M | $185.1M | ||
| Q3 25 | $292.8M | — | ||
| Q2 25 | $293.9M | — | ||
| Q1 25 | $294.9M | — | ||
| Q4 24 | $295.9M | $202.7M | ||
| Q3 24 | $521.7M | — | ||
| Q2 24 | $522.5M | — | ||
| Q1 24 | $523.3M | — |
股东权益MRVIRDI
| Q4 25 | $212.4M | $-18.2M | ||
| Q3 25 | $245.4M | $-12.1M | ||
| Q2 25 | $265.9M | $-7.7M | ||
| Q1 25 | $300.6M | $-8.1M | ||
| Q4 24 | $325.3M | $-4.4M | ||
| Q3 24 | $344.9M | $1.6M | ||
| Q2 24 | $434.7M | $6.5M | ||
| Q1 24 | $410.7M | $18.0M |
总资产MRVIRDI
| Q4 25 | $770.6M | $434.9M | ||
| Q3 25 | $849.2M | $435.2M | ||
| Q2 25 | $897.0M | $438.1M | ||
| Q1 25 | $959.8M | $441.0M | ||
| Q4 24 | $1.0B | $471.0M | ||
| Q3 24 | $1.3B | $495.7M | ||
| Q2 24 | $1.4B | $494.9M | ||
| Q1 24 | $1.4B | $494.9M |
负债/权益比MRVIRDI
| Q4 25 | 1.37× | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | 1.11× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 0.91× | — | ||
| Q3 24 | 1.51× | — | ||
| Q2 24 | 1.20× | — | ||
| Q1 24 | 1.27× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.8M | $4.3M |
| 自由现金流经营现金流 - 资本支出 | $-24.9M | $4.1M |
| 自由现金流率自由现金流/营收 | -49.9% | 8.2% |
| 资本支出强度资本支出/营收 | 4.2% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-70.7M | $-2.9M |
8季度趋势，按日历期对齐
经营现金流MRVIRDI
| Q4 25 | $-22.8M | $4.3M | ||
| Q3 25 | $-15.2M | $295.0K | ||
| Q2 25 | $-10.3M | $1.6M | ||
| Q1 25 | $-9.4M | $-7.7M | ||
| Q4 24 | $-14.6M | $8.0M | ||
| Q3 24 | $13.1M | $1.3M | ||
| Q2 24 | $17.4M | $-10.4M | ||
| Q1 24 | $-8.5M | $-2.8M |
自由现金流MRVIRDI
| Q4 25 | $-24.9M | $4.1M | ||
| Q3 25 | $-18.1M | $-246.0K | ||
| Q2 25 | $-13.1M | $1.2M | ||
| Q1 25 | $-14.6M | $-8.0M | ||
| Q4 24 | $-20.5M | $7.0M | ||
| Q3 24 | $4.5M | $-1.1M | ||
| Q2 24 | $7.9M | $-10.6M | ||
| Q1 24 | $-14.1M | $-4.7M |
自由现金流率MRVIRDI
| Q4 25 | -49.9% | 8.2% | ||
| Q3 25 | -43.4% | -0.5% | ||
| Q2 25 | -27.7% | 1.9% | ||
| Q1 25 | -31.2% | -19.8% | ||
| Q4 24 | -36.2% | 12.0% | ||
| Q3 24 | 6.6% | -1.8% | ||
| Q2 24 | 11.4% | -22.7% | ||
| Q1 24 | -22.0% | -10.4% |
资本支出强度MRVIRDI
| Q4 25 | 4.2% | 0.3% | ||
| Q3 25 | 7.0% | 1.0% | ||
| Q2 25 | 6.1% | 0.6% | ||
| Q1 25 | 11.2% | 0.6% | ||
| Q4 24 | 10.3% | 1.7% | ||
| Q3 24 | 12.4% | 4.0% | ||
| Q2 24 | 13.8% | 0.5% | ||
| Q1 24 | 8.8% | 4.3% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MRVI
| Cygnus Segment | $27.2M | 54% |
| Other | $18.4M | 37% |
| Shipping And Handling | $4.3M | 9% |
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
